NCI's Gong Xingfeng Reports Strong Start in Dividend Insurance Transition, 2026 Focus on Expanding Product Portfolio

Deep News03-30

On March 30, NCI held its 2025 annual results presentation. President and Chief Financial Officer Gong Xingfeng stated that the company firmly advanced its dividend insurance transition in 2025, successfully achieving a favorable start, primarily reflected in breakthroughs at the sales level.

Gong Xingfeng emphasized that 2025 marks only the beginning of the dividend insurance transition. In 2026, the company will continue to deepen this transformation, with a key focus on broadening product types, increasing sales efforts for risk annuities, and strengthening product innovation. The company plans to capitalize on the policy benefits for dividend health insurance, enhance product suitability management, adhere to selling appropriate products to suitable customers, and resolutely avoid sales misconduct.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment